Why the study?
The biologic significance of superoxide dismutase in transformed gastric carcinoma cells was unclear, prompting examination of its role as a prognostic indicator and its association with clinicopathological factors.
Does the expression of MnSOD and Cu/ZnSOD correlate with prognosis and clinicopathological factors in patients with gastric carcinoma?
Observational
Does the expression of MnSOD and Cu/ZnSOD correlate with prognosis and clinicopathological factors in patients with gastric carcinoma?
p-value: p=<0.05
MnSOD immunoreactivity is significantly associated with poor outcome in gastric carcinoma patients, suggesting its potential as a prognostic biomarker.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted an observational in Gastric carcinomas and adenomas. MnSOD and Cu/ZnSOD expression was evaluated on Patient prognosis and clinicopathological factors (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: